𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Leukocytapheresis in a girl with severe ulcerative colitis refractory to corticosteroids, infliximab, and cyclosporine A

✍ Scribed by Katalin Dittrich; Markus Richter; Wolfgang Rascher; Henrik Köhler


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
461 KB
Volume
14
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Infliximab or cyclosporine as rescue the
✍ Mats Sjöberg; Andrea Walch; Mina Meshkat; Anders Gustavsson; Gunnar Järnerot; Ha 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 1 views

Background: Cyclosporine (CsA) or infliximab (IFX) are used as rescue therapies in steroid-refractory, severe attacks of ulcerative colitis (UC). There are no data comparing the efficacy of these two alternatives. Methods: Outcome of rescue therapy was retrospectively studied in two cohorts of pati

Corticosteroids but not infliximab incre
✍ M. Ferrante; A. D'Hoore; S. Vermeire; S. Declerck; M. Noman; G. Van Assche; I. H 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 1 views

## Background: Recent reports suggest that the preoperative use of infliximab (ifx) increases postoperative infectious complications in patients with ulcerative colitis (uc). therefore, we determined the impact of ifx on postoperative infectious complications. ## Methods: A consecutive group of 1

Multidrug resistance gene-1 polymorphism
✍ Fady Daniel; Marie-Anne Loriot; Philippe Seksik; Jacques Cosnes; Jean-Marc Gorne 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Background: Cyclosporine A (CsA) is inconstantly effective in inducing remission in acute attacks of ulcerative colitis (UC) not responding to steroids. This study aimed to establish whether multidrug resistance gene (MDR)1 polymorphisms would be associated with CsA failure. ## Patients and Methods